Hydroxystilbamidine isethionate
Hydroxystilbamidine isethionate is a small molecule pharmaceutical. Hydroxystilbamidine isethionate was first approved as Hydroxystilbamidine isethionate on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Hydroxystilbamidine isethionate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| HYDROXYSTILBAMIDINE ISETHIONATE | Sanofi | N-009166 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
63 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pain | D010146 | EFO_0003843 | R52 | — | 2 | 1 | 1 | 1 | 5 |
| Pharyngitis | D010612 | R07.0 | — | — | 2 | 1 | — | 3 | |
| Postoperative pain | D010149 | G89.18 | — | — | — | 1 | 1 | 2 | |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | 1 | — | 1 |
| Toothache | D014098 | K08.89 | — | — | — | 1 | — | 1 | |
| Dental pins | D003772 | — | — | — | 1 | — | 1 | ||
| Dry eye syndromes | D015352 | H04.12 | — | — | — | 1 | — | 1 | |
| Analgesia | D000698 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ischemic stroke | D000083242 | — | — | 1 | — | — | 1 | ||
| Hyperglycemia | D006943 | HP_0003074 | R73.9 | — | — | 1 | — | — | 1 |
| Eczema | D004485 | HP_0000964 | L30.9 | — | — | 1 | — | — | 1 |
| Chronic renal insufficiency | D051436 | N18 | — | — | 1 | — | — | 1 | |
| Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | — | — | 1 | — | — | 1 |
| Dyspepsia | D004415 | EFO_0008533 | K30 | — | — | 1 | — | — | 1 |
| Abdominal pain | D015746 | R10.9 | — | — | 1 | — | — | 1 | |
| Malabsorption syndromes | D008286 | EFO_0009554 | K90 | — | — | 1 | — | — | 1 |
| Stomach diseases | D013272 | — | 1 | 1 | — | — | 1 | ||
| Capsule endoscopy | D053704 | — | 1 | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Local anesthesia | D000772 | — | 1 | — | — | 2 | 3 | ||
| Critical illness | D016638 | — | 1 | — | — | — | 1 | ||
| Cerebrovascular disorders | D002561 | EFO_0003763 | I60-I69 | — | 1 | — | — | — | 1 |
| Dental anesthesia | D000766 | 1 | 1 | — | — | — | 1 | ||
| Asthma | D001249 | EFO_0000270 | J45 | — | 1 | — | — | — | 1 |
| Otitis media | D010033 | EFO_0004992 | H66.9 | — | 1 | — | — | — | 1 |
| Gingivitis | D005891 | K05.10 | 1 | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | — | 2 | 3 |
| Oral lichen planus | D017676 | 1 | — | — | — | 2 | 3 | ||
| Oral ulcer | D019226 | HP_0000155 | 1 | — | — | — | — | 1 | |
| Staphylococcal infections | D013203 | A49.01 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypotension | D007022 | EFO_0005251 | I95 | — | — | — | — | 1 | 1 |
| Orthodontic anchorage procedures | D052280 | — | — | — | — | 1 | 1 | ||
| Body weight | D001835 | EFO_0004338 | — | — | — | — | 1 | 1 | |
| Overweight | D050177 | E66.3 | — | — | — | — | 1 | 1 | |
| Glucose metabolism disorders | D044882 | — | — | — | — | 1 | 1 | ||
| Open-angle glaucoma | D005902 | EFO_0004190 | H40.1 | — | — | — | — | 1 | 1 |
| Lichen planus | D008010 | L43 | — | — | — | — | 1 | 1 | |
| Weight loss | D015431 | HP_0001824 | — | — | — | — | 1 | 1 | |
| Feeding behavior | D005247 | — | — | — | — | 1 | 1 | ||
| Duchenne muscular dystrophy | D020388 | — | — | — | — | 1 | 1 |
Show 19 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | HYDROXYSTILBAMIDINE ISETHIONATE |
| INN | — |
| Description | Hydroxystilbamidine is a fluorescent dye that emits different frequencies of light when bound to DNA and RNA. It is used as a retrograde tracer for outlining neurons, and as a histochemical stain.
|
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | N=C(N)c1ccc(/C=C/c2ccc(C(=N)N)cc2O)cc1.O=S(=O)(O)CCO |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL1200847 |
| ChEBI ID | — |
| PubChem CID | 5353676 |
| DrugBank | — |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 15 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
215 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more